======= A1CF ======= == Gene Information == * **Official Symbol**: A1CF * **Official Name**: APOBEC1 complementation factor * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=29974|29974]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NQ94|Q9NQ94]] * **Interactions**: [[https://thebiogrid.org/search.php?search=A1CF&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20A1CF|Open PubMed]] * **OMIM**: [[https://omim.org/entry/618199|Open OMIM]] == Function Summary == * **Entrez Summary**: Mammalian apolipoprotein B mRNA undergoes site-specific C to U deamination, which is mediated by a multi-component enzyme complex containing a minimal core composed of APOBEC-1 and a complementation factor encoded by this gene. The gene product has three non-identical RNA recognition motifs and belongs to the hnRNP R family of RNA-binding proteins. It has been proposed that this complementation factor functions as an RNA-binding subunit and docks APOBEC-1 to deaminate the upstream cytidine. Studies suggest that the protein may also be involved in other RNA editing or RNA processing events. Several transcript variants encoding a few different isoforms have been found for this gene. [provided by RefSeq, Nov 2010]. * **UniProt Summary**: N/A |RRM 1| |apolipoprotein B mRNA editing enzyme complex| |mRNA localization resulting in posttranscriptional regulation of gene expression| |intracellular mRNA localization| |cytidine to uridine editing| |base conversion or substitution editing| |mRNA modification| |single-stranded RNA binding| |double-stranded RNA binding| |mRNA binding| |RNA modification| |protein stabilization| |RNA localization| |regulation of protein stability| |mRNA processing| |posttranscriptional regulation of gene expression| |mRNA metabolic process| |RNA processing| |endoplasmic reticulum| |RNA binding| |cellular macromolecule localization| |RNA metabolic process| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp458|Bisphenol S 100μM R08 exp458]]|-2.13| |[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|-1.95| |[[:results:exp111|R-DABN 8μM R03 exp111]]|-1.85| |[[:results:exp490|Hydroxychloroquine 30μM R08 exp490]]|-1.7| |[[:results:exp249|Vinorelbine 0.001μM R05 exp249]]|1.74| ^Gene^Correlation^ |[[:human genes:h:hgc6.3|HGC6.3]]|0.4| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 6771 * **Expression level (log2 read counts)**: 1.03 {{:chemogenomics:nalm6 dist.png?nolink |}}